Financial Services / Insurance - SpecialtyNYSE
$5.62
-0.07 (-1.23%)
Book/ROE base 3Y
n/d
n/d CAGR · P/B n/d
Book/ROE base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 100% · confianza 20%
Book/ROE escenarios
weak_data · book/share n/d · quality 92.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
29/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$286M
P/E
N/A
•EV/EBITDA
N/A
•ROE
7.9%
↑Gross Margin
N/A
•Debt/Equity
-1.50
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2008–2025 · 17 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
47.5%
FCF / Net income
-0.21x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $80.0M · net income $-177.0M · FCF $38.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||||
| Revenue | $80.0M | $80.0M | $42.0M | $7.0M | $154.0M | $189.0M | $282.0M | $280.0M | $162.0M | $433.0M | $294.0M | $853.0M | $1.27B | $1.21B | $2.44B | $-1.56B | $894.0M | $2.95B | $-856.6M |
| Net Income | $-177.0M | $-177.0M | $-447.0M | $-491.0M | $-203.0M | $-445.0M | $-578.0M | $-359.0M | $-296.0M | $-1.60B | $-338.0M | $180.0M | $569.0M | $250.0M | $1.23B | $-1.32B | $53.0M | $634.0M | $-2.67B |
| EPS | -3.58 | -3.58 | -9.43 | -10.18 | -4.08 | -8.99 | -9.78 | -4.43 | -3.33 | -13.50 | -2.54 | 1.06 | 2.76 | 1.29 | 6.33 | -6.85 | 0.26 | 2.99 | -12.11 |
| Net Margin | -221.3% | -221.3% | -1064.3% | -7014.3% | -131.8% | -235.4% | -205.0% | -128.2% | -182.7% | -370.7% | -115.0% | 21.1% | 44.8% | 20.7% | 50.7% | 84.7% | 5.9% | 21.5% | 312.0% |
| Balance Sheet | |||||||||||||||||||
| Debt/Equity | -1.50 | -1.50 | -1.54 | -1.91 | -3.52 | — | — | 2.70 | 2.01 | — | 0.62 | 0.51 | 0.46 | 0.52 | 0.55 | — | — | — | — |
| Current Ratio | 3.72 | 3.72 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||||||
| Free Cash Flow | $38.0M | $38.0M | $-176.0M | $-195.0M | $-418.0M | $510.0M | $-390.0M | $-368.0M | $-320.0M | $-653.0M | — | — | — | — | $-1.03B | $-2.63B | $-951.0M | $-2.20B | $-167.0M |
| Returns | |||||||||||||||||||
| ROE | 7.9% | 7.9% | 21.4% | 29.6% | 23.0% | 142.2% | -425.0% | -43.5% | -26.5% | — | -10.5% | 4.8% | 14.5% | 7.6% | 38.9% | -77.6% | 1.9% | 24.5% | -268.8% |
| Growth & Yield | |||||||||||||||||||
| Revenue Growth | 90.5% | 90.5% | 500.0% | -95.5% | — | -33.0% | 0.7% | 72.8% | -62.6% | 47.3% | -65.5% | -32.8% | 5.0% | -50.3% | 256.4% | -274.2% | -69.7% | 444.9% | — |
| EPS Growth | 62.0% | 62.0% | 7.4% | -149.8% | — | 8.1% | -120.8% | -33.0% | 75.3% | -431.5% | -339.6% | -61.6% | 114.0% | -79.6% | 192.4% | -2734.6% | -91.3% | 124.7% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+27.2%
Start / end P/E
n/dx → n/dx
EPS bridge
-9.43 → -3.58
Residual
+27.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.